Interim results of a major study suggest that some individuals with mild cognitive impairment or dementia who are taking Alzheimer disease medication may not really have the disease.
Recent research presented at the 2017 ASCO Meeting found that after implementation of the ACA, there was a slight increase in the percentage of cancers diagnosed at an earlier, more treatable stage.
Steven R. Feldman, MD, PhD, discusses how to improve treatment adherence and outcomes in patients with psoriasis.
Aminah Jatoi, MD, outlined strategies for preventing and managing nausea and vomiting caused by chemotherapy treatment.
Value-based care is here to stay—requiring experimentation, course correction, and application of new lessons in order to optimize the success of payment models.
Lawrence Schimmel, MD, highlighted how data analytics are crucial to understanding the future of health care spending and management.
Gary Owens, MD, will discuss emerging therapies and strategies for improving patient outcomes related to management of Relapsing Multiple Sclerosis as part of the population health management track sessions at the NAMCP 2017 Spring Managed Care Forum.
Managed care professionals and health care executives will gather at the upcoming NAMCP Spring Managed Care Forum 2017.
Researchers showed that a low dose of Xarelto reduced the risk of venous thromboembolism (VTE) in patients at high risk for a recurrence of blood clots.
Treatment with sodium glucose cotransporter-2 (SGLT-2) inhibitors significantly reduced risk of hospitalization for heart failure and all-cause mortality.